An Esophageal Neoplasm Sans Lineage: Undifferentiated Carcinoma

Undifferentiated esophageal carcinoma is an infrequently encountered but highly aggressive variant of esophageal cancer, recently recognized by the World Health Organization as a distinct pathological entity. It lacks definitive lineage-specific differentiation and represents <4% of all esophageal malignancies. We here report a middle-aged male with progressive dysphagia and weight loss, diagnosed with metastatic undifferentiated esophageal carcinoma and initiated on palliative chemotherapy and immunotherapy. Despite its rarity, undifferentiated neoplasia poses significant diagnostic and therapeutic challenges due to its aggressive nature and the absence of established treatment protocols. This case underscores the importance of comprehensive histopathologic and immunophenotypic evaluation in modern-day oncology. Further research is essential to elucidate the molecular mechanisms underpinning dedifferentiation, explore targeted therapies, and improve outcomes in this highly malignant tumor subset.